Maxi-Strip Skin Closure Strips: What Wound-Closure Procurement Should Verify

Maxi-Strip Skin Closure Strips

Maxi-Strip Skin Closure Strips are listed for closure of lacerations, surgical incisions, and use following early suture or staple removal. That places the product in postoperative and emergency wound management rather than primary surgical repair.

The stated benefits emphasize wound support and tensile strength relative to sutures, along with reduced scarring and infection risk from a non-invasive, sterile design. These are the manufacturer’s claims and should be checked against the unit’s clinical protocol before standardization.

Two sizes are listed: 13×102 mm and 6.4×102 mm. Both share the same packaging figures — inner box of 50, outer box of 1500 — so a single case delivers 30 inner boxes regardless of width.

The width split matters operationally. Narrower 6.4 mm strips and wider 13 mm strips suit different incision lengths and tension profiles, so buyers should confirm which size each clinical area actually consumes rather than substituting one for the other.

The input does not give shelf life, adhesive composition, or sterility-validation documentation. Those records are typically required for hospital qualification, so they must be requested from the supplier rather than assumed.

Because both sizes ship in identical case quantities, inventory planning is straightforward on volume but not on mix. A department that uses mostly 6.4 mm strips will accumulate surplus of the wider variant if ordering is not split by size.

Strip closure only works as a system: the strip, the skin-preparation routine, and the removal interval have to be specified together. Procurement that treats it as a simple line item tends to find the gap during a clinical audit.

Why it matters:
Verify size mix, sterility documentation, and shelf life before standardizing. The clinical claim is the supplier’s; the qualification evidence is the buyer’s responsibility.

View Product →